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Abstract
Globally, contraceptive studies and their use are major challenges in the
realm of public health. The ideal goal is to obtain a contraceptive method that
is highly effective at minimizing unplanned pregnancies and nullifying the
chance of contracting a sexually transmitted disease. Abstinence is currently
the only way to attain such a dualistic goal, and while effective, it may not be
suitable for sexually active individuals. While there is an abundance of methodspecific information regarding the use of any one female contraceptive device,
there is a paucity of resources that compare and contrast the advantages and
disadvantages of such methods and enable an individual to optimize family
planning. This paper attempts to address many of these topics by reviewing a
multitude of U.S. Food and Drug Administration (FDA) approved contraceptive
methods. This work is intentionally written towards educating medical students,
educators and teachers at all levels of training with foundational knowledge
regarding female contraception.
Keywords: Female contraceptive methods; Food and drug administration;
Abstinence

Introduction
In the United States, unplanned pregnancy continues to be a
polarizing public health concern. Contraceptive methods remain
a point of contention in American politics and public culture. At
the same time, the United Nations Millennium Development Goals
aim to increase access to reproductive health [1]. Between 2011 and
2013, approximately 62% of women between ages 15 and 44 in the
United States used a contraceptive method. The groups least likely to
utilize contraceptive methods included women ages 15 to 24, Latinas,
and those with a high school diploma or less [2]. While a myriad of
options exist for the prevention of pregnancy and sexually transmitted
infections (STIs), the population most drastically affected by unplanned
pregnancy is younger women [3]. This is further complicated across
the globe by lack of awareness and access to contraceptive methods.
It is suggested that at least 10% of married women have an unmet
need for family planning. In certain regions, this number is even
higher, especially in sub-Saharan Africa and Oceania [4]. It has been
demonstrated that discussion of sexual and reproductive issues with
both families and students improves awareness and may increase
utilization of methods to prevent pregnancy and sexually transmitted
diseases, even in populations in the developing world [5]. Data
from Switzerland, where contraception is less taboo, suggest that
condom use is the most common method utilized by adolescents,
particularly at first intercourse [6]. In the United States, health beliefs
and social discussions about contraception have a major influence
on health practices rather than methods based on evidence. In
urban populations, it has been demonstrated that misconceptions
regarding emergency contraceptive methods are largely gleaned
from the opinions of individuals close to them [7]. Importantly, the
limited use of female contraception is an issue shared by both male
and female sexual partners. Generally, men lack knowledge regarding
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the available options for their female partners. Increased awareness
and understanding of hormonal contraception by men can increase
access to these methods and improve adherence [8]. Despite these
issues, contraceptives are used by 64% of married or in-union women
globally [4]. Though a divisive issue, for the improvement of women’s
health across the globe, it is imperative to improve understanding of
the available methods. The proceeding discussion describes the use,
risks, benefits, and costs of a number of female contraceptive methods.
The aim of this review is to provide a comprehensive summary of
these factors for each FDA approved contraceptive method as well as
a discussion of the ethical implications of contraception visualized in
the accompanying Quick Table.

Contraceptive Methods
Abstinence
Abstinence is a behavioral method of contraception in which
individuals avoid engaging in any type of sexual activity altogether
including but not limited to oral, anal, or vaginal intercourse.
Abstinence is the only way a person can be completely certain of
the prevention of pregnancy or infection with sexually transmitted
diseases (STDs). Among older women, abstinence may reflect a
genuine choice related to age. 10.4% of women between the ages of
35 and 49 were likely to use abstinence as a contraceptive choice,
whereas 8.3% and 8.1% of women ages 25-34 and 15-24 respectively
practiced abstinence [9].
Abstinence is a reversible, non-invasive, free of financial cost
method of contraception. This practice does not have any risks or
medical/hormonal side effects. Abstinence-related risks occur when
women decide to no longer abstain from sex. One of the most common
failures of abstinence is failure to avoid sexual activity, which can lead
to a lack of planning for alternative forms of contraception.
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uncontrolled diabetes mellitus, and thromboembolic disease [11].

Figure 1: Intrauterine device [13].

This may cause some women to end periods of abstinence without
having an alternative form of contraception [9]. There are no health
contraindications associated with the use of abstinence as a form of
contraception. If a woman believes that she will not be able to abstain
from sex for extended periods of time, she should not consider
abstinence as her primary form of birth control [10]. Consideration
should also be given to psychological factors, such as confidentiality
and cultural factors that may affect the choice of abstinence as a
primary modality of contraception.
Copper T intrauterine device
The Copper T Intrauterine Device (IUD) is a reversible, nonhormone based method of female contraception with a unique ability
to work in an efficient manner for a prolonged period of time [11].
As shown in Figure 1, the Copper T IUD is a T-shaped polyethylene
flexible structure containing 380 mm of copper wire situated
throughout its stem and arms [12].
The Copper T IUD is installed into the uterus [12]. The
insertion process tends to be uncomplicated, with the most
common complication from insertion being perforation. For the
Copper T-380A IUD, perforation rates for insertion occur at a rate
of 1.5 per 1,000 [14]. Once inserted, the Copper T IUD impedes
fertilization through the virulent effects that copper has on the sperm
and ovum, and by acting as a physical barrier to the sperm’s voyage
towards the egg [11]. In multiple trials, the Copper T IUD has proven
to be an effective form of female contraception, revealing the risk of
pregnancy while utilizing this device is 0.6% [15].
Though Copper IUDs have been in production for decades, in the
1980s, IUDs were criticized due to their inability to prevent sexually
transmitted diseases, causing a decline in their utilization [16]. In the
early history of the copper T IUD, liability claims negatively affected
the use of the device and eventually manufacturers were forced to
remove them off of the market. Eventually, one of the removed
copper T IUDs was reinstituted into the market [16]. Copper T
IUDs are a very practical form of contraception. After the insertion
of the Copper T there is no need for patient follow up with her
healthcare professional for dosing administration as seen with most
hormone based methods [11]. The Copper T IUD becomes effective
immediately after insertion. More so, being hormone free makes this
method safe for use for women with breast cancer, hypertension,
Submit your Manuscript | www.austinpublishinggroup.com

The uninterrupted use of the Copper T IUD has been approved
for 10 years, meaning that a woman utilizing this Copper T IUD can
keep it inserted for 10 years and it will work successfully for up to 12
years [11]. As previously mentioned, the Copper T IUD is reversible,
which is made possible through the use of a string attached to the
base of the T frame facilitates the process of removal and reversibility.
After removal, the woman physiologically returns to fertility and the
processes of ovulation typically occur anywhere from 10-14 days
after removal. The use of Copper T IUD has possible side effects,
including escalated bleeding during menstrual cycles, cramping and
increased menstrual pains [11]. Although, in many patients these side
effect diminish over time, they might vary in length depending on
the age of the patient. The most profound reason for the removal of
Copper IUDs is attributed to excessive vaginal bleeding which may
result due to improper sizing of the device relative to the patient’s
uterine cavity [16]. There are several other contraindications and side
effects summarized in Table 1. Studies have specifically shown that
the Copper T 380A IUD is one of the most affordable methods of
contraception with the 5-year cost of use estimated at $1,678 USD
without insurance [17].
Levonorgestrel IUD
Intrauterine devices containing Levonorgestrel are an effective
and reversible form of long term contraception. Levonorgestrel is a
synthetic form of progesterone used in many oral contraceptives and
contraceptive implants. The Levonorgestrel intrauterine device, as
shown in Figure 2, delivers a dose of Levonorgestrel daily for up to
five years [18].
Levonorgestrel physiologically functions by restricting the growth

Figure 2: Levonorgestrel intrauterine device [19].

Figure 3: Female contraceptive implant [23].
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Table 1: Female contraceptive – quick table guide.
Adverse reactions

Length of
Action

Technique

Usage

Abstinence

Nonparticipation
of vaginal
intercourse

No adverse reactions
Variable
known.

Copper T
IUD

Copper T IUD
is installed into
the uterus [12].
Once
inserted, the
Copper T
IUD impedes
fertilization
through killing
both sperm and
egg cells while
physically
obstructing the
sperm’s voyage
towards the egg
[11].

Escalated bleeding
during menstrual
cycles and increased
menstrual pains are
common. Very
rare reports including
expulsion of the IUD,
pelvic inflammatory
disease, or ruptures
during the insertion
process [11].
Studies
have identified a rare
link between Copper
T IUD and Human
Papillomavirus
(HPV) [113].

The
uninterrupted
use of the
Copper T
IUD has been
approved for
10 years [11].

Invasiveness

Non-Invasive

Reversibility

Reversible

Invasive requires a
procedure
Reversible
conducted by
[11].
a healthcare
professional
[11].

Cost ($ - $$$)

No cost.

Estimated
cost is $1,678
without
insurance
[114].
$$$

Levonorgetsterel
IUD

Miscarriage, preterm
birth, possible
infection, pelvic
inflammatory
disease, possible
The device is
development of
implanted every ovarian cysts [17].
5 years [17].
Less serious but
possible side effects
include nausea,
mood changes,
weight gain and
dizziness [17].

The
contraceptive
effect of the
IUD lasts for
up to 5 years
after device
placement [17].

Invasive as
the device is Reversible
inserted in the [17].
uterus [17].

Approximately
$1,646 every 5
years [20].
$$$

Implant

Potential risk
of bruising and
infection at the site
The implant
of injection.
can be inserted Abdominal, back, or
every 3-5 years breast pain, irregular
[25].
vaginal bleeding,
headaches, nausea,
weight gain, ovarian
cysts [27].

Depending on
the model and
dosage of
progestin, the
implant can be
effective for 3-5
years [23].

Invasive as
it is a small
flexible rod
Reversible
that is inserted
[21].
under the skin
of the upper
arm [21].

$0-$800,
varies with
insurance [21].
$$$

Injection

Amenorrhoea, heavy
bleeding, or frequent
bleeding, weight
Injections
gain, and decreased
are typically
bone mineral density
repeated
are among the
every one to
most common side
three months
effects [32]. Many
depending on
side effects are
the hormone
not harmful and
being used [32]. are reduced 12 to
18 months after
discontinued use
[33].

Depending on
the hormone
being used,
injections can
be
effective for
one month
(Lunelle), eight
weeks
(NET-EN), or
three months
(DMPA) [32].

Minimally
invasive with
slight
discomfort
at the site of
injection [16].

Submit your Manuscript | www.austinpublishinggroup.com

Reversible
with delay.
Ovulation
may take
from
14 weeks to
18 months to
resume [115].

$50 - $60 per
injection, $0
with insurance
[36].
$-$$

Patient
Considerations
This method has
been proven to work
best in young, single
women and women
reaching the end of
their reproductive
years. This method
also works better
among educated
couples than less
educated couples [9].

This method of
contraception is nonhormone based. It is
safe for women with
breast cancer,
hypertension,
uncontrolled
diabetes mellitus,
and thromboembolic
disease [11].

This method is
convenient for
women seeking
a long term
contraceptive
method. The
levonorgestrel
IUD should not be
used by patients
who experience
unexplained vaginal
bleeding or in
patients who have
been diagnosed
with chlamydia or
gonorrhea [19].
Useful for patients
desiring a longlasting contraceptive
method. The implant
cannot be
inserted in pregnant
women and should
not be used by
women with a history
of breast cancer,
liver disease, blood
clots, or irregular
vaginal bleeding [23].
Injections are safe for
most women and can
be used by women
of reproductive age.
Women who are
pregnant as well as
those with severe
hypertension or
vascular disease,
cancer, and liver
disease should
not use injectable
contraceptives [30,
34].

Important Information

Anyone can practice
abstinence. There is
no link
between religious
affiliation and an
individual's decision to
remain abstinent [9].

The probability of
pregnancy while
utilizing this device is
0.6% [15].

This intrauterine device
is 99% effective [17].

Successfully prevents
more than 99% of
pregnancies. It doesn't
protect against STIs
[25].
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This method of
contraception is
usually prescribed
to adolescent and
young women.
However, combined
oral contraceptives
Each pill lasts
can be used by any
about 24 hours
healthy reproductive
Venous
- taken
$30-50 per
aged female.
Combined
Taken at the
thromboembolism,
continually oral
Reversible
monthly
Women who are
Oral
same time daily ypertension, stroke, contraceptives Non- invasive with timedelay pack, $0 with heavy smokers,
Contrace[39].
myocardial infarction are effective
[39].
insurance [39]. have sickle cell
ptives
[40].
until
$$
disease, previous
discontinued
cardiovascular
[40].
illnesses and
those who have
gallbladder disease
should avoid taking
combined oral
contraceptives due to
increased risk of side
effects [40].
Women
contraindicated with
Irregular bleeding,
estrogen based
headaches, nausea,
contraceptives,
Progestin only
Reversible
breast tenderness,
those suffering
pills should be
with time
acne, weight gain to This
with migraines or
taken at the
delay [45].
a lesser degree,
contraceptive
smokers over the
same time each
Non-invasive After 24$20 - $50,
formation of ovarian method is
age of 35, benefit
Progestin
day and have a
form of
hours
varies with
cysts, reduced
effective
from this
Only
three
contraception without the
insurance [46].
efficacy from other
until dismethod [42]. Women
hour window
[19].
pill, cervical
$$
medications
continuation
should not use if
for maximum
mucus
processed by the
[30].
they have acute
effectiveness
normalizes
liver, higher rates of
liver disease, breast
[34].
[37].
ectopic pregnancies
cancer, pregnancy,
[30,42].
genital bleeding,
or cardiovascular
disease [30].
Women should not
use this method if
Effective until
The vaginal
they smoke over the
ring is manually
discontinuation.
Vaginal secretion,
age of 35 and have
inserted into the
Efficacy is
Moderately
breast tenderness,
Reversible
coronary artery
vagina and worn
reduced if a
invasive
headache, nausea,
with time
disease, diabetes,
3 weeks and
new ring
through
$0 to $80 [51].
Hormonal
vaginitis, coital
delay postLupus, severe
is not utilized
insertion into
$-$$
Vaginal Ring then taken out
issues, foreign body
discontihypertension,
for 7
within 24 hours the vagina
sensation, and ring
nuation [49].
thromboembolic
days to allow
after the 7-day [49].
expulsion [30, 34].
disorders, known
endometrial
shedding
pregnancy, or
shedding [30].
period [48].
localized migraines
[30].
This method of
contraception can be
used by all women.
Can be used
However it is not as
as a form of
Somewhat
effective as the
Sponge
Toxic shock
contraception invasive form
Birth Control
other forms of
placed before
syndrome, vaginitis, for up to 24
of
Reversible.
$
Sponge
contraception.
intercourse [53]. irritation [57].
hours after
contraception
For safety, it is
sponge is
[53].
advised that the
inserted [55].
sponge not be used
during menses or
puerperium [57].

Submit your Manuscript | www.austinpublishinggroup.com

Progestin-only
contraceptive pills
were developed as an
alternative to estrogen
in combination
oral contraceptives
which led to increased
risk of
venousthromboembolytic events
[43].

Available over the
counter [58].
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Diaphragm
or Cervical
Cap

Impedes the
sperm from
making its way
into the
cervix by being
positioned
in a manner
that covers the
cervix. This is
considered an
invasive
method of
contraception
[57,60].

Female
Condom

Every time
Allergies, not always Whilst having
there is sexual
100% effective
sex
intercourse [64]

Spermicide

Chemical agent
that impair the
sperm’s mobility
by disabling the
sperm to
move into the
vagina or killing
the sperm cell
[59].

Advised time
limit of usage
Applications of
of 1-year for
diaphragms with
a diaphragm.
spermicides may
With
increase the
regular
probability of urinary maintenance,
tract infections [57]. lifespan can be
stretched to
two years [57].

May cause a higher
risk urinary tract
infections (UTI) from
women that use
spermicides as a
form of
contraception vs.
those that apply
distinct contraception
methods
[70]. May cause
irritations and
allergic reactions to
the woman or her
counterpart [59].

Typically,
spermicides
should be left
on for 6-8
hours after
intercourse in
order to work
efficiently [69].

Invasive
method of
Reversible
contraception [57].
[60].

$

Indications for the
use of diaphragms
are made if the
patient is unable to
use hormonal
contraceptives, if the
patient is 6 weeks
postpartum, and
if the patient has
rare sexual activity
among other factors
[57].

Not very
invasive, easy Reversible
to apply and [64].
remove [64]

$6 for 3
condoms,
[66]. $

Good for both
partners to avoid
pregnancy and
STDs [66]

Somewhat
invasive form
Reversible
of
[59].
contraception
[59].

Good for any
Reasonably
woman who is
priced and
unable to utilize
affordable [70].
hormonal forms of
$
contraception [59].

The efficiency is
increased when used
with barrier
devices like
diaphragms or cervical
caps [62].

The method should
work similarly for all
women.
Around $20 for In the US, it is more
thermometer
effective among
and calendar/ white women
fertility
between 19 and 29
awareness
years of age who are
chart.
in long-term, stable
$
relationships, and
have high school
education or higher
[72].

This method is
associated with a lower
incidence of
induced abortion in the
US, and with a divorce
rate lower than the
general
American population
[72].

Costs range
from $0 to
$6,000, varies
with insurance
[79].
$$-$$$

Associated with a
lower incidence, stage,
and
mortality of endometrial
and ovarian
carcinomas [80].

Natural
Planning or
Fertility
Awareness

Performed
monthly
Avoid sex during
Non-invasive
No adverse reactions during fertile
fertile days of
form of
Reversible.
known.
days of the
the month.
contraception.
menstrual cycle
[71].

Tubal
Ligation

Not 100% effective.
Pregnancy remains
a possibility in 5
Before or after a out of
pregnancy.
1000 women after a
year, and in 13 out of
1000 women after 5
years [75].

Transcervical
Sterilization

Before or after
a pregnancy.
Method
prevents
pregnancy and
doesn't protect
against STIs.

Approximately 8%
of first attempts
at procedure are
unsuccessful [89].
Procedure may
cause pain,
dizziness, nausea, or
light bleeding.
Potential risk of
ectopic pregnancy
or the insert moving
out of place (can be
removed if needed)
[90].
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Permanent
length of action
after
contraceptive
method is
performed.

After the
occlusion is
confirmed,
length of action
is permanent
[83].

Invasive
form of
contraception.
Surgery is
performed,
most of the
time via
laparoscopy
[75].

Reversible
with tubal
anastomosis. May
have
therapeutic
limitations.
[77].

Invasive as
the procedure
is
performed
Irreversible
hysteroscopically
[87].

Best for older
women and women
who already have
children.

Mostly a permanent
method of
contraceptive.
Suggested for older
women.
Not recommended
for women that are:
- Currently pregnant,
$0-$6,000,
- Delivered
varies with
or terminated
insurance [92]. pregnancy 6 weeks
$$-$$$
prior to insertion
- Recent pelvic
infection
- Proximal tubal
occlusionCurrently taking
immunosuppressants
- Have a unicornuate
uterus [91].

There are in fact
allegations of a type of
diaphragm made from
silicone
elastomer that has the
unique ability
to release an
administered dose of
spermicide,
Nonoxynol-9 (N-9) [62].

Over-the-counter, more
effective than male
condoms [68]

Prior to the complete
occlusion, it suggested
to use another method
of
contraceptives to
prevent pregnancy
[87].
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Headache, nausea,
1-5 days
and low possibility of
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pelvic inflammatory
intercourse [96].
disease [97,98].
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Once after
sexual
intercourse
[93].

Non invasive,
just taking of a Irreversible
pill [93].

$50 purchased
overthecounter,
less if covered
by insurance
[97].
$$

Good for female
trying to avoid
pregnancy after
having sexual
interaction [94].

Some work better
than others and are
highly time dependant.
MechanismPreventing sperm
to fertilize an egg.
Not equivalent to the
"abortion pill" [96].

Note: USD = U.S.
$: $0 - 20; $$: $20-100.
Dollar $$$: >$100.

skin, as seen in Figure 3. Similar to a levonorgestrel IUD, the implant
releases progestin, a hormone that can be used to prevent pregnancy
[22].

Figure 4: The Depo-Provera contraceptive injection [29].

Physiologically, Progestin acts to thicken the mucus of the cervix
which impedes cervical sperm transport. The implant differs from
the levonorgestrel IUD in that high doses of synthetic progestin
can prevent ovulation [22]. The implant is effective for 3-5 years,
depending on the product and model used [24]. The implant can be
used by women of all ages. Less than 1% of women with an implant
become pregnant, rendering this a highly effective method [25]. It
cannot prevent against sexually transmitted infections (STIs), so it is
commonly used alongside methods that prevent STIs [26].
The implant is inserted by a trained health care provider as part
of a routine in-office procedure [22]. The upper arm is cleaned and an
anesthetic is used to numb the area, after which a needle applicator is
used to insert the device(s). The site heals within 3-5 days. In order for
the implant to be removed, a local anesthetic is used prior to making a
small incision in the arm. The implant is then pulled out. If desired, a
new implant can be placed in the same location [27]. The implant can
be removed any time during the 3-5 year effective period. Once the
implant is removed, the female hormone cycle resumes normality. If
one does not desire pregnancy, a new birth control method should be
used immediately [22].

Figure 5: Combined oral contraceptive pack [38].

of the endometrium. The thinning of the endometrium creates a
harsh environment unsuitable for the blastocyst implantation [20].
Intrauterine device placement is a rather invasive procedure, as the
device is inserted into the uterus through the vagina and cervix [18].
The levonorgestrel IUD is 99 % effective. The 5-year cost without
insurance estimate of using the Levonorgestrel uterine device is about
$1,646 USD [21]. Some side effects associated with the implantation
of the intrauterine device include nausea, mood changes, and changes
in bleeding patterns, acne, dizziness, headaches, weight gain and
the possible development of ovarian cysts. Other rare but possible
complications related with the use intrauterine devices include the
perforation of the wall of the uterus, miscarriage, preterm birth and
possible infection [18]. The device should not be used by patients who
exhibit unexplained vaginal bleeding and in patients who have been
diagnosed with chlamydia or gonorrhea since IUD insertion can lead
to the development of pelvic inflammatory disease (PID) [20].
Hormone implant-extrauterine
A non-intrauterine female hormone based contraceptive implant
consists of a small bendable rod approximately 4 cm in length that
is inserted into a woman’s upper arm subdermally, just under the

Submit your Manuscript | www.austinpublishinggroup.com

Although uncommon, bruising or infection in the area of the
injection can occur. The implant may cause irregular vaginal bleeding
as well as abdominal, back, or breast pain. There is also a risk of
headaches, nausea, weight gain, or developing ovarian cysts [27]. It
should not be inserted during pregnancy. The implant also should
not be used in women that have history of breast cancer, liver disease,
blood clots, or irregular vaginal bleeding [24]. Depending on both
the brand used and insurance, the implant can cost up to $800 per
insertion and up to $300 for removal (USD) [22].
Depot injection
Injectable contraceptives are shots of the progestin hormone,
specifically depot medroxyprogesterone acetate (DMPA), injected
intramuscularly or subcutaneously in the arm or the buttocks
[28]. Figure 4 illustrates the most widely used form of injectable
contraceptives, Depo-Provera.
Medroxyprogesterone
acetate
(MPA
or
Lunelle),
Norethisteroneenantate (NET-EN), and Mesygina are less commonly
used injectables which are administered in a similar manner [29]. The
main function of the injectable method is to prevent ovulation by
altering the endometrial lining by blocking the action of luteinizing
hormone [30]. It is important to note that this method does not
protect against STDs.
Austin J Reprod Med Infertil 4(2): id1049 (2017) - Page - 06
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Combined oral contraceptives
Combined oral contraceptives, more commonly known as birth
control pills, contain a combination of two female hormones: estrogen
and progestin [37]. Figure 5 illustrates a standard pill package for this
method of contraception.

Figure 6: Progestin birth control pills [41].

DMPA has been available in other countries like Indonesia,
Mexico, and Thailand since the 1960s. Originally approved in the
United States for the treatment of endometriosis and habitual
abortion in 1960, DMPA was later approved for contraceptive use
in 1992 after an extensive study published by the World Health
Organization (WHO). This study revealed that DMPA led to no
significant increases in breast or uterine cancers. The injection is
composed of an aqueous solution containing suspended microcrystals. Other injectables are widely used outside of the United States
due to ease of continuity [31].
DMPA must be repeated every twelve weeks or three months at
150 mg/1 mL while NET-EN must be repeated every eight weeks at
200 mg/1 mL. Lunelle is repeated monthly [32]. The micro-crystals
containing the hormones are in solution and slowly released into
the blood over time. With every injection, there is an increase in
progestrogen levels during the first 24 to 48 hours followed by a steady
decline in the following weeks [33]. After discontinuation, it may take
up to 12 to 18 months for contraceptive effects to wane [34,35].
Injectable contraceptives are minimally invasive with slight
discomfort at the site of injection [30]. DMPA is completely reversible
and may be used by women of all ages. Injectable contraceptives are
considered a method of long-acting reversible contraception. After
discontinuing treatment, ovulation may take 14 weeks to 18 months to
return [35]. Some common side effects include bleeding abnormalities
such as amenorrhea (absence of menstrual periods), heavy bleeding,
or frequent bleeding. Other effects include weight gain and decreased
bone mineral density [32]. Many of these side effects are not harmful
and are reduced 12 to 18 months after discontinuation [31, 33].
Injectable contraceptives are safe for most women. However,
some contraindications exist among women who are pregnant and
those with severe hypertension or vascular disease [30]. Women with
diabetes can use injectable contraceptives, but this may lead to an
adverse effect on glucose metabolism. Women with liver disease such
as acute hepatitis, liver carcinoma, and liver cirrhosis generally should
not use DMPA as it is metabolized in the liver. Women with breast
cancer should also not use DMPA [34]. Injectable contraceptives are
the most cost effective after one year of use [35]. Without insurance,
the shot alone - excluding the cost of physician consultation charges
ranges from $50 - $60 per injection. With insurance, the cost may be
completely reduced to $0 [36].
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Progestin is associated with the majority of the contraceptive
activity of the pill. The progestin component thickens the cervical
mucus which makes it more difficult for sperm to enter the cervix
leading to the uterus. It also suppresses the production of hormones
that control ovulation. The estrogen component serves as a suppressor
of hormones that cause ovulation [37]. If there is no ovulation,
pregnancy cannot occur. Combined oral contraceptives should be
taken at the same time daily. If taken exactly according to package
directions only 3 out of 1000 women will become pregnant. Thus,
combined oral contraceptives are 97% effective [39]. However, when
used without complete adherence to instructions, there is a failure
rate of 9%.
Potential side effects associated with combined oral
contraceptives include an increased risk of cardiac problems such
as venous thromboembolism, arterial thrombosis, myocardial
infarction, hypertension a n d stroke. These risks are more likely
to occur in women with a previous history of hypertension, heavy
smoking, sickle cell disease, cardiovascular diseases, gallbladder
disease, or have a pre-existing hypertension. Noncardiac associated
side effects include migraines and esophageal reflux. Women who
have a previous history of depression may experience worsening of
their symptoms [40]. Combined oral contraceptives are a reversible
and non-invasive form of contraception. Women who stop taking the
oral contraceptive pill will have a two week delay in the resumption
of ovulation. Brand named combined oral contraceptives usually
cost around $50 USD monthly. However, there are generic options
available which sell for around $30 per pack (USD). Many insurance
providers do not cover the cost of combined oral contraceptives;
however, some offer a co-pay option where the patient only pays a
fraction of the cost [39].
Progestin only oral contraceptive
Progestin-only contraceptive pills, also known as mini pills,
contain 35%-75% of the progestin contained in combination pills and
must be taken at the same time each day [30]. Figure 6 illustrates a
standard 28-day progestin pill package.
Unlike combination pills, these do not contain estrogen. About
9 out of 100 women become pregnant when using the pill correctly
during the first year [34]. They function by reducing the amount
of follicle-stimulating hormone (FSH) and luteinizing hormone
(LH) while suppressing ovulation for about 50% of cycles [34]. In
addition, they help to thicken cervical mucus which helps to prevent
the penetration of sperm [30]. This method does not protect against
STDs.
Progestin-only contraceptive pills have been available as a
method of birth control since the 1960s [42]. They were initially
developed to avoid the high dosage of estrogen in combination oral
contraceptives which led to increased risk of venous thromboembolic
events. Estrogen dosages have been significantly reduced over the
past few decades, but the development of progestin-only pills was
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Hormonal vaginal ring
The hormonal vaginal contraceptive ring is a flexible device
placed inside the vagina that releases a combination of the hormones
estrogen and progestin. The ring is worn for 21 days taken out
during menstruation. After menstruation, a new ring is inserted to
begin the following cycle [30]. Figure 7 illustrates the proper method
of self-inserting the vaginal ring after consultation with a healthcare
provider.

Figure 7: How to insert a vaginal ring [47].

promoted to reduce such risks [43]. Women contraindicated with
estrogen based contraceptives, such as those suffering with migraines
or smokers over the age of 35, have been able to benefit from this
method [42]. According to the National Survey of Family Growth,
approximately 0.4% or 250,000 women between the ages of 15 and 44
currently use progestin-only pills [43].
Pills must be taken daily within the same 3-hour window for
maximum effectiveness [34,44]. After 48 hours, full effects occur in
the cervical mucus [44]. Progestin-only pills are non-invasive and
taken orally [34]. This method of contraception is known as a shortacting hormonal method [45]. After a 24-hour period without the
pill, cervical mucus normalizes. The normal ovulation cycle returns
faster for these women than those on the combination pill [37].
Possible risks associated with progestin-only pills include
formation of ovarian cysts and reduced efficacy from other
medications processed by the liver. Common side effects include
irregular bleeding, headaches, nausea, breast tenderness, acne,
and weight gain to a lesser degree [30]. Women using this method
also have a higher rate of ectopic pregnancies compared to women
that use other methods [42]. Absolute contraindications for this
contraceptive method include acute liver disease, breast cancer,
pregnancy, or genital bleeding [30]. A relative contraindication is
current cardiovascular disease such as venous thromboembolism
[42,43]. The cost of progestin-only pills typically range from $20-$50
per month (USD) for those without insurance coverage. Those with
insurance may have their prescription fully covered or may have a
higher copay depending on the brand. Additional costs may include a
visit to the physician and tests such as a pelvic exam which could range
anywhere from $35 to $250 (USD) depending on insurance coverage.
Some pharmacies and universities offer discounts on generic versions
of these pills [46].
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Approximately 9 out of 100 women using this method become
pregnant during their first year of use [47]. This method inhibits
ovulation and alters the composition of the cervical mucus.
Contraceptive rings offer the lowest dose of estrogen out of all
combined contraceptives. It does not protect against transmission
of STDs [30]. The contraceptive ring was developed as a means of
delivery of a constant small dosage (about 120 mcg of etonogestrel
and 15 mcg of ethinyl estradiol per day) over a sustained period of
time due to low rates of continuity with oral contraceptives. The first
studies conducted on this novel idea were published in the 1960s,
and with time, new components were added and altered [48]. The
ring, measuring about 54 mm in diameter, is currently made of the
polymer ethylene vinyl acetate. The outermost layer is the portion that
releases hormones evenly over time [30]. The most commonly used
brand, Nuva Ring, was approved for contraceptive use in 2001 by the
FDA [48]. For the ring to be effective, the device does not require a
specific positioning in the vagina. However, it will be less likely to fall
out the further back it is placed. The hormonal vaginal ring secretes
hormones continually and is used for three weeks followed by a weeklong period where it is withdrawn [49]. Efficacy is reduced if a new
ring is not put into place within 24 hours after the 7-day period [58].
The hormonal vaginal ring is moderately invasive through insertion
into the vagina. This may cause some discomfort for some women,
and the device may be easily dislodged [54]. After discontinuation
of the vaginal ring, all effects are rapidly reversible with ovulation
resuming in as little as a few days or as long as a few months [49].
Typical side effects of the vaginal ring include increased vaginal
secretion, breast tenderness, headache, nausea, and vaginitis [30]. Many
of these effects are similar to those of other combined contraceptives.
Effects and r isks specifically associated with this device include
coital issues, foreign body sensation, and ring expulsion [30,34].
Vaginal rings are safe for most women of reproductive age. Absolute
contraindications for this method are shared with all other forms
of combination contraceptives including coronary artery disease,
diabetes, Lupus, and severe hypertension. Relative contraindications
include thromboembolic disorders, cigarette smoking in women over
the age of 35, known pregnancy, and localized migraines [30]. Some
studies reveal that this method may decrease total cholesterol [50].
The vaginal ring itself, available in one universal size, costs up to $80
(USD) depending on insurance coverage. Additional costs associated
with a physician visit and physical exams can range up to $250 (USD).
Some clinics and drugstores offer to charge based on an individual’s
income [51].
The birth control sponge, shown in Figure 8, is a type of
contraception used in the birth canal. The sponge contains a
spermicide to prevent fertilization. In addition to the spermicide,
the sponge also has virucidal and bactericidal components that can
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are two kinds of contraceptive caps which are the diaphragm and
the cervical cap [60]. Diaphragms tend to be larger in size than the
cervical cap, about the size of the palm of the hand [60]. Cervical
caps are much smaller, about the size of a small egg cup [60]. Use of
the diaphragm is more common than that of the cervical cap. To use
the diaphragm, a woman must situate the device in such a manner
that it will barricade the sperm from reaching the cervix [60]. The
majority of diaphragms are installed in a dome down method, but
certain forms of diaphragms exist that can be placed in a dome up
position [59]. The less common cervical cap has to be positioned
directly on the cervix to detain the sperm from entering [60]. The
preference between a cervical cap and the diaphragm are dependent
on the woman, though typically women find it troublesome to keep
the diaphragm in place due to their vaginal shape. For this reason,
cervical cap use is more common in the United States [60].
Diaphragms are typified by their dome shape visualized in Figure
9. They are flexible and made of silicone with a spring activated rim
which serves to obstruct sperm from reaching the cervix [59]. The
diaphragm is kept in place by these rims which may be a flat- spring
rim, coil-spring rim, or an arcing-spring rim generating a seal around
the vaginal wall [59]. The diaphragm is a non-hormonal method of
contraception. Diaphragms are frequently used alongside spermicides,
utilizing chemical contraceptives such as Nonoxynol-9 to further
facilitate and aid in the prevention of unwanted pregnancies [59].
When employing a diaphragm it is endorsed to apply two strips of
spermicide on the superior surface of the diaphragm [59].

Figure 9: Diaphragm [61].

potentially serve as protection from STDs [53]. Most birth control
sponges contain Nonoxynol-9, which immobilizes sperm through
the disruption of the sperm cell membrane. Findings show that
this spermicide can impede diseases such as gonorrhea, chlamydial
infection, candidiasis, genital herpes, syphilis, trichomoniasis and
HIV [54]. However, it is highly advised that aside from the birth
control sponge, other protection be used to prevent these diseases.
The sponge can be used as a contraception method for up to 24
hours. The birth control sponge was developed as an alternative to
the contraceptive diaphragm [65]. This method of contraception
is among the least effective, failing approximately 10% percent of
the time [56]. However, some studies show that the sponge is only
75% effective [57]. Possible risks that can occur when using the
birth control sponge include pregnancy, irritation, discomfort and
vaginitis. A rare side effect is toxic shock syndrome. It is advised
that the sponge not be used during menses or during the six week
period after childbirth [58]. The birth control sponge is available over
the counter. This method of contraception is relatively inexpensive
ranging from $10 to $15 (USD).
Diaphragm or cervical cap
The diaphragm is a method of female contraception that impedes
sperm from entering the cervix, as shown in Figure 9 [59]. There
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Current research and design initiatives are focused on a type of
diaphragm made from silicone elastomer that has the unique ability
to release an administered dose of spermicide, Nonoxynol-9 (N9) [62]. For a patient to acquire a diaphragm, fitting must take place.
The process of fitting is done through pelvic exam [59]. A diaphragm
is a removable method of contraception [59]. Following the
withdrawal of a diaphragm it must be rinsed in lukewarm water with
soap and dried [59]. There is an advised time of use of one year for a
diaphragm, but if properly maintained, this lifespan can be stretched
to two years [59]. There may be a need to for a refitting postpartum,
or if the patient has had a 15 pound change in weight, or following
any gynecological procedures [59].
Indications for the use of diaphragms include inability to use
hormonal contraceptives, postpartum status, and low frequency of
sexual activity [59]. Contraindications for the use of a diaphragm
include gynecological abnormalities, insufficient vaginal muscletone, wounds in vaginal wall, and critical cystocele or rectocele among
other factors [59]. Possible side effects include the possibility of
urinary tract infections (UTIs) [59]. Today, diaphragms and cervical
caps have been overshadowed by oral contraceptives. They are only
used by a small population of women, and currently are experiencing
low approval among women [63].
Female condom
The female condom is a barrier contraceptive that functions
similarly to a male condom. However, it is worn by the female partner
internally rather than the external covering of the male condom. The
main function of this contraceptive method is to protect against
pregnancy and sexually transmitted diseases. It creates a physical
separation between the genitals using a polyurethane material,
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of spermicide distribution [63].

Figure 10: Female condom [65].

visualized in Figure 10 [64].
The female condom has two flexible rings at the end, one which
is used to insert the condom inside the vagina, and the other which
covers the outer parts of the external genitalia [64]. This product
was created was to give women more control over the prevention
of STDs [66]. A man might refuse to wear a condom but by using
this, the female can protect herself accordingly. Moreover, this
method of contraception allows for insertion prior to intercourse
without disrupting sexual activity [67]. Even though this method of
contraception is not used as commonly as the male condom, it is still
just as available and offers the same or better protection than its male
counterpart.
The female condom offers some benefits over the male condom.
Providing women with a condom suited to their anatomy increases
the control women have over their health [67]. The polyurethane
material is thicker and is less susceptible to forming holes than latex
[64]. It is also a great alternative for those who might have a latex
allergy. In terms of protection provided, studies suggest that the
female condom is just as protective as the male condom, if not more
so. The female condom can reduce the risk of women getting HIV by
90% [68].
Female condoms are readily available to obtain for anyone of
any age or gender. These condoms are found at local drugstores in
the United States (US), without a prescription, for approximately $6
(USD) for a box of eight depending geographic location in the US. No
identification is required to buy this contraceptive method, thus age is
not a restriction in obtaining them. Moreover, the female condom is
provided via Medicare for beneficiaries in 32 states [66]. They are also
available at some family planning centers or local health centers, such
as a Planned Parenthood health center free of charge.
Spermicide
Spermicides are chemical agents that disrupt the sperm cell
membrane, decrease sperm motility and eventually destroys
the sperm. The most commonly used spermicides include N-9
methoxy polyoxyethylene glycol 55 laurate, and p-methyl phenyl
polyoxyethylene [59]. Spermicides come in various forms including
cream, foam, soluble film, jelly, tablet, and suppositories. This method
of contraception commonly supplements other methods such as
diaphragms and cervical caps among others. Research shows that the
resulting rate of pregnancy with spermicide use is 6 to 18% compared
with 26 to 28% with just the conventional barrier method. However,
the efficiency of spermicides is increased when used with barrier
devices like diaphragms and cervical caps as previously discussed.
Possible reasons for mechanism failure include reduced contact times
between the semen and spermicide. Other reasons include the failure
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Due to their availability, spermicides are a common method of
contraception around the world. Typically, spermicides should be
left on for 6 to 8 hours after intercourse in order to work efficiently
[69]. The application of spermicides varies depending on the
specific spermicide being utilized. If the spermicide is being used as
a supplement contraceptive it is typically recommended to situate
the barrier contraceptive with the spermicide in a way that it covers
the cervix. In a scenario in which a woman is utilizing a spermicide
delivered as foam, intercourse has to take place instantly after
application. If a woman is utilizing jellies and creams the wait time
for intercourse should be 2 to 3 minutes after application. In dealing
with suppositories and foaming tablets the wait time for intercourse
should be 3-15 minutes after the application of the spermicide.
Finally, when dealing with soluble films the wait time for intercourse
should be 30 minutes and these times should not be exceeded [59].
Studies show that women who utilize diaphragms supplemented
by spermicides have a higher possibility of acquiring a urinary tract
infection (UTI). Some of the adverse reactions include a higher risk
UTIs in women that use spermicides as a form of contraception than
women that apply distinct contraception methods. Patients that are
pregnant or plan to get pregnant are advised against spermicides
due to the unfavorable effects including spontaneous abortions and
development of Down syndrome [70].
Natural planning or fertility awareness
Contraceptive methods based on fertility awareness are those
methods that involve the identification of monthly fertility patterns
in women. Natural awareness methods predict women’ s fertility
by identifying physical signs and symptoms, such as cervical
secretions and basal body temperature, which change with hormonal
fluctuations during the menstrual cycle [71]. Women who do not
want a pregnancy practice sexual abstinence during the days of the
month in which they are fertile. Usually, women who choose natural
planning or fertility awareness as a contraceptive method fall between
the ages of 19 and 29 years old.
Fertility awareness-based methods are performed monthly during
the menstrual cycle. The method is highly effective as long as women
avoid having sex during days of ovulation/fertile days [71]. These
methods are noninvasive and do not require medical procedures
performed by a physician. Fertility awareness-based methods of
contraception are fully reversible. They can be conversely used as a
pregnancy method by engaging in sexual activity during the fertile
days of the menstrual cycle [72].
Contraindications include physical separation and lack of support
from male partners that contribute to the failure or discontinuation
of fertility awareness-based methods. Unless women have adequate
communication, respect from their parents, deeper intimacy, and a
working understanding of the reduced frequency of sexual intercourse
involved with this method, then fertility awareness-based methods
are contraindicated [72]. One of the benefits of this fertility awareness
method is its low cost.
Tubal ligation
Tubal ligation, a method of female sterilization, is a type of
permanent birth control by which a woman has her fallopian tubestied,
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closed, or cut to prevent a pregnancy. The procedure is intended to
block the passage of eggs from the ovaries into the fallopian tubes,
where they could be fertilized by sperm [73]. Though available since
the early 1900s, it was not until the 1960s when cultural changes
increased the popularity of female contraception and millions of
women had more access to sterilization procedures, such as tubal
ligation, when insurance companies decided to cover them [73].
Tubal ligation is more common among women who belong to
minority groups, and those who have lower income and education
levels [74]. Similar to other permanent methods of contraception,
tubal ligation tends to be more common in older women and
women who already have children. About 700,000 tubal ligations
are performed in the United States each year, with approximately
eleven million US women relying on it as their primary method of
contraception [75]. This is a highly effective method of permanent
contraception; however, it is not one hundred percent effective. One
year after the procedure, five out of one thousand women (0.5%) have
a risk of becoming pregnant. Five years after the procedure, around
thirteen out of a thousand women (1.3%) may have become pregnant
[75].
Tubal ligation is a surgical procedure which blocks, ties, or cuts
the fallopian tubes. It can be done by laparoscopy in which a viewing
and a surgical instrument are inserted through two small incisions in
the abdomen. Tubal ligations performed after childbirth is performed
via mini-laparotomy within 36 hours of the baby being delivered [75].
Ligation can also be accomplished with the use of tubal implants.
These implants are small metal springs inserted in the fallopian
tubes in a nonsurgical procedure that only requires local anesthesia
or oral analgesics [76]. The cervix is first dilated and then a catheter
that places the implant passes through the cervix into the uterus
and into the fallopian tubes. An X-ray is taken after the procedure
to assure that the implants were placed correctly and that the tubes
are closed [76]. When tubal implants, such as Essure, are used, the
sterilization is not immediately effective which forces women to use
additional contraception for another three months until permanent
tubal ligation occlusion is verified [76]. Both surgical and nonsurgical
methods of tubal ligation are performed by a gynecologist or general
surgeon.
Depending on the age of the patient, the method of tubal ligation,
and the overall health of the reproductive organs, tubal ligation
reversal– or tubal anastomosis– is possible. Tubal ligation reversal is
done by laparoscopy in which the surgeon unties the tubes or removes
any implants that block them [77]. The surgeon then proceeds to
reconnect the ends of the tubes to the uterus. When compared
to in vitro fertilization (IVF) procedures, tubal ligation reversal was
the most cost-effective method for women less than 41 years of age
who desired to become pregnant after a previous tubal ligation [77].
For women older than 41, the success rate of pregnancy after tubal
ligation was higher with the use of IVF than by tubal ligation reversal.
Complications stemming from tubal ligation procedures are
uncommon. However, of the minor complications possible, infection
and separation of the wounds are the most likely. Major complications
that could occur are severe blood loss, anesthesia-related problems,
need for a larger incision during surgery, and perforation of organs
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when the laparoscope is inserted into the abdominal cavity. Risks
associated with the surgery tend to increase when women suffer
from other conditions, such as diabetes, obesity, or cardiovascular
problems.
In the event that tubal ligation is not effective, a pregnancy is likely
to occur, with an increased risk of ectopic pregnancy [78]. Ectopic
pregnancies happen when a fertilized egg implants in the fallopian
tubes or other regions of the abdomen rather than in the uterus.
This condition requires emergency treatment. Symptoms of ectopic
pregnancies include nausea, vomiting, abdominal cramps, weakness,
and pain on one side of the body. An ectopic pregnancy could lead to
fallopian tube rupture and cause severe pain and bleeding.
The uncertainty of a patient in regards to tubal ligation is a
contraindication for this type of birth control. The decision to
perform a tubal ligation should be treated as a permanent, irreversible
procedure, despite the possibility of a future tubal ligation reversal
or a pregnancy through in vitro fertilization [78]. The patient should
ask for the procedure herself, without external pressure, when she is
in a competent state of mind to make such decisions. Tubal ligation
performed via laparoscopy is contraindicated in patients suffering
from diaphragmatic hernias and severe cardiopulmonary diseases
[73]. Compression of the vena cava diminishes cardiac return,
leading to cardiac decompensation. Splinting of the diaphragm by
laparoscopic techniques may also reduce respiratory tidal flow [73].
Considerations needs to be given to obese patients in which the
presence of morbid obesity take laparoscopy out of the list of lowrisk surgeries when safer procedures are available. For gynecologic
pathologies, such as ovarian tumors and pelvic relaxation, in which
hysterectomies are suggested, the use of laparoscopic tubal ligation is
obviated. The current costs of tubal ligation range from $0 to $6,000
(USD). The mean cost for the tubal ligation procedure was $5,163
(USD) among commercially insured women in the United States.
During a six-month follow-up of 7,286 women who had undergone
laparoscopic bilateral ligation, the total medical and prescription
costs were $7,568 (USD) [79].
Tubal ligation has been associated with lower incidence, stage, and
mortality among women with aggressive endometrial carcinomas.
Tubal ligation prevents the passage of endometrial carcinoma cells
from the fallopian tubes into the peritoneum, which seems to be a
crucial step in the development of endometrial cancer [80]. Tubal
ligation has also been associated with reduced risk of invasive ovarian
cancer. The tubal ligation procedure has protective effects that are
mediated by the ablation or prevention of ovarian seeding by precancerous cells from the uterus and fallopian tubes [80].
Transcervical sterilization
Transcervical sterilization is a permanent method of birth
control. As shown in Figure 11 & 12, a small metal coil is inserted
into each of the two fallopian tubes [82]. Over the next 3 months, scar
tissue forms around each of the metal coils and acts as a plug which
prevents transport and fertilization of eggs [83].
Sterilization does not protect against sexually transmitted
infections, so a method of STI prevention should be used in addition
to this procedure. The first transcervical sterilization method was
approved in the United States in 2002 [85]. It is the second most
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device can be removed by a follow-up surgical procedure [90].
Sterilization should not be performed for women that are
currently pregnant, delivered or terminated pregnancy 6 weeks prior
to insertion, had a recent pelvic infection, proximal tubal occlusion,
are currently taking immunosuppressants, or have a malformed
uterus known as unicornuate uterus [91]. Depending on the facility
and insurance used, sterilization can cost between $0 and $6,000
(USD) [92].
Emergency contraception

Figure 11: Forms of tubal ligation [81].

Figure 12: Insertion of transcervical sterilization coil. a) Applicator handle b)
Uterus c) Flexible catheter d) Tubal ostium e) Fallopian tube f) Micro-insert
[84].

commonly used contraceptive method for women between the ages
of 15-44 and has been used by approximately 9.4 million women in
the United States [86].
Sterilizations can be performed either laparoscopically through
a small set of incisions made in the abdomen, or hysteroscopically
through a tube that is inserted through the vagina that allows for
visualization of the uterus [87]. Progress has been made to replace
minimally invasive techniques with even less invasive techniques that
can be performed using only anesthesia to numb the affected area
and without the need for incision [88]. The hysteroscopic procedure
is considered to be a one-day procedure in which the woman can
return to her normal activities within the same day of treatment
[82]. Sterilization is a permanent me t ho d of birth control and is
not reversible. However, other methods of birth control should be
used in the three months following application while the scar tissue
takes its time to form and plug the fallopian tube [87]. Women may
experience some discomfort during or after the procedure such as
pain, dizziness, nausea, or light bleeding.
Approximately 8% of first attempts at placing the insert are
unsuccessful [89]. If the fallopian tube is not completely blocked
off, due to misplacement, additional birth control methods should
be used to prevent pregnancy [90]. Once a healthcare provider
confirms that the fallopian tube is completely occluded, transcervical
sterilization is effective at preventing more than 99% of pregnancies
[83]. If pregnancy does occur, there is an increased likelihood that
the pregnancy is ectopic. In the case of injury or continuous pain, the
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Emergency contraceptive is a broad, umbrella term for chemical
contraceptives that can be taken or implanted after unprotected
sexual intercourse [93]. The way an emergency contraceptive works is
in prevention of the fertilization of an egg by a sperm even after sexual
intercourse. It is used only as a method to prevent pregnancy, not to
prevent the transmission of sexually transmitted diseases [94]. The
benefit of this contraceptive method is to prevent pregnancy from
outside sources such as the failure of another contraceptive method,
partner refusal, or other sexual assault, among others. There are two
main types of emergency contraceptives: the morning-after pill and
copper IUD.
The morning-after pill lowers the chances of pregnancy but is
less effective than OCPs. This pill estimates a range of effectiveness
between 52% and 94% in reducing pregnancy risk [95]. Under this
category there are two pills that are the most widely used- Ella and
Plan B. The Ella pill is most effective and can be used up to 5 days after
unprotected sex, but requires a prescription. It works by preventing
ovulation, even during the time in your cycle when a woman is most
fertile, for five full days following unprotected sex [96]. The Plan-B pill
is not as effective and can be used up to 5 days after unprotected
intercourse, but works better the earlier it is used. However, unlike
Ella, no prescription is needed. Plan-B works by stopping the release
of an egg from the ovary and by preventing fertilization of the egg
[97]. For both pills, there are several side effects such as headaches
and nausea, but few users have demonstrated serious adverse effects
[97].
The copper IUD is a copper-releasing device that is placed in the
uterus and is used to prevent a pregnancy. It can be placed up to five
days after having unprotected sex. It has an effectiveness of 99% after
placement for the next ten years [98]. Using a copper IUD, however,
does have side effects, namely a longer and heavier period for several
months a n d increased possibility of pelvic inflammatory disease
[98]. This method requires a prescription by a health care provider.
Using a copper IUD requires removal prior to attempting becoming
pregnant.

Ethical Considerations
State laws
The Patient Protection and Affordable Care Act of 2010 commonly
referred to as Obamacare or the ACA is a federal law that has set a
standard of health care coverage for nationwide insurance companies.
A key provision of this law pertaining to reproductive health requires
that counseling or educational services and contraceptive methods
including diaphragms, sponges, birth control pills, vaginal rings,
IUDs, emergency contraception, and sterilization are covered at no
additional cost, without a copayment or coinsurance [99].
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Some state laws have been revised to match or expand the
requirements outlined by the ACA. For instance, three statesCalifornia, Illinois, and Vermont-now mandate insurance coverage
of over -the-counter contraceptive methods although they may
require a valid prescription [100]. In addition, many states including
California, District of Columbia, Hawaii, Illinois, Oregon, and
Vermont have expanded the ACA requirements to cover an extended
supply of contraceptive methods. An extended supply would mean
that enough treatment f or one year is provided during one visit
[100]. Despite recent attempts to repeal the ACA, some states like
Virginia have made strides towards protecting coverage of female
contraceptives by introducing state laws that will explicitly continue
coverage even without the ACA [101].
Minors and consent laws
Consent laws outline the age and conditions at which one is able to
agree to contraceptive treatments, testing and treatment for sexually
transmitted infections, prenatal care, abortion services, adoption
services, prenatal healthcare, and healthcare for the minor’s child
[102]. A majority of states, in addition to the District of Columbia,
allow minors as young as 12 years old to consent to contraceptive
treatments given that they meet the state’s criteria as previously
mentioned. However, Alabama, Hawaii and Pennsylvania only
allow minors of 14 years of age or older to consent to such services
[103]. All minors, women under the age of 17, are allowed access
to testing and treatment for sexually transmitted infections [102].
Each state differs in their policies that explicitly allow for minors
to consent to contraceptive services. Some states can allow for all
minors to consent while other states require that other criteria be met
including: minimum age, current parenthood, current pregnancy or
previously pregnancy, high school graduation, maturity, or physician
determination that the minor’s health is at risk.
Currently, there are 25 states that require circumstances to be met
in order for minors to be eligible to manage their use of contraceptive
services without guardian involvement. For instance, restrictive state
policies can be found in states like Connecticut, Indiana, Michigan,
or Vermont in which minors can only can consent if they are married
[103]. A total of 21 states, in addition to the District of Columbia,
allow all minors to consent. Of those 22 locations, states such as
Kentucky, Maryland, Minnesota, Montana, and Oregon provide
physicians the choice to inform the minor’s parents. However states
such as Massachusetts, New York, and Wyoming provide confidential
services, meaning that the minor’s health care decisions are kept
private. There are 4 states - North Dakota, Ohio, Rhode Island, and
Wisconsin - that currently do not have explicit policies about minor
consent [103].
Contraceptive methods are typically equally effective for women
of all ages. However, age, alongside potential desire of children
in the future, is an important factor considered when determining
an appropriate method, especially for irreversible contraceptive
treatments.
Rape/Incest
Rape is understood to be non-consensual sexual intercourse
between two people. However, in the United States the age of sexual
consent varies from 16-18 years old depending on the state [104].
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Accordingly, it is illegal for anyone to have a sexual encounter
with anyone under 16-18 years old depending on the state, though
exceptions may apply when the person is married or if the other
party is a minor and the sexual activity is consensual [105]. Studies
have indicated that at least half of children born to female minors
are fathered by adult men, also known as statutory rape [106]. One
method to empower women to have more control in unequal sexual
relationship is to increase their access to and the availability of
emergency contraceptives. There have been some cases in which rape
victims were not allowed to be prescribed emergency contraceptives
[107]. However, now with the establishment of federal and state rape
laws, all states provide necessary care for rape victims [108].
Incest is usually defined as sexual intercourse between members
of an immediate family. This includes between a father and his child,
a mother and her child, or siblings [109]. Different states, however,
have different laws defining incest and how it is to be addressed in a
court of law. These definitions of incest can include sexual intercourse
between stepfamilies - such as a stepfather with his stepdaughter.
Rape and incest can be closely affiliated and often co-occur if one
party is a minor and cannot consent. Similar to rape laws, if a person
experiences incest, all states provide emergency contraceptives or
abortion methods in order to avoid unwanted pregnancy [108].
Ethical case example
Contraception has been an area of discussion and debate in the
world of ethics and medicine. Many religious backers do not find it
moral for people to use contraceptive methods because it prohibits
a life from forming that some higher power might have desired
wanted that life to be born. Notably, in the Zubik v. Burwell case from
2016, some employer’s insurance users are looking for an insurance
company that will not provide contraceptive coverage because of
their religious beliefs and ideologies [110]. Moreover, another big
issue with the field of contraceptives is the ambiguity with how
exactly these contraceptives work [111]. Push back from the FDA
with approval of pills such as Ella or Plan B were once a very big issue
for anyone who might be taking these emergency contraceptives but
they have now been cleared and allowed to be used by the general
public.

Conclusion
Currently, the most common methods of contraception used in the
United States are combined oral contraceptives, female sterilization,
the male condom, and IUDs, respectively. In recent years, the use of
IUDs has increased as the lack of evidence of association with their use
and PID has been widely disseminated. However, despite the increase
in utilization of female contraceptive methods, tremendous tumult
exists surrounding the discussion of a woman’s right to reproductive
freedom. Though outside of the scope of this discussion, it remains
of critical importance that women are able to obtain the information
necessary to learn more about each method, its proper use and the
statistics regarding its efficacy. The preceding discussion outlined the
use of sixteen FDA approved contraceptive methods in addition to
an ethical consideration of the issues of contraception in the United
States. The provided Summary Table 1 is intended to be used as a
quick reference tool for both students and those looking to compare
methods for personal use. The information provided above does not
substitute for the judgment of a trained medical professional.
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